Search Results

Calcifediol monohydrate 5mg 5mg  | Purity Not Available

Adooq Bioscience

Calcifediol monohydrate(25-hydroxy Vitamin D3) is a prehormone that is produced in the liver by hydroxylation of vitamin D3 (cholecalciferol) by the enzyme cholecalciferol 25-hydroxylase.

More Information Supplier Page

Calcifediol monohydrate 10mg 10mg  | Purity Not Available

Adooq Bioscience

Calcifediol monohydrate(25-hydroxy Vitamin D3) is a prehormone that is produced in the liver by hydroxylation of vitamin D3 (cholecalciferol) by the enzyme cholecalciferol 25-hydroxylase.

More Information Supplier Page

CAL-130 Hydrochloride 50mg 50mg  | Purity Not Available

Adooq Bioscience

CAL-130 Hydrochloride is a novel phosphoinositide 3-kinase (PI3K) inhibitor. It is reported that combined inhibition of PI3K??/?? as therapy for T cell acute lymphoblastic leukemia (T-ALL).

More Information Supplier Page

CAL-130 Hydrochloride 5mg 5mg  | Purity Not Available

Adooq Bioscience

CAL-130 Hydrochloride is a novel phosphoinositide 3-kinase (PI3K) inhibitor. It is reported that combined inhibition of PI3K??/?? as therapy for T cell acute lymphoblastic leukemia (T-ALL).

More Information Supplier Page

CAL-130 Hydrochloride 10mg 10mg  | Purity Not Available

Adooq Bioscience

CAL-130 Hydrochloride is a novel phosphoinositide 3-kinase (PI3K) inhibitor. It is reported that combined inhibition of PI3K??/?? as therapy for T cell acute lymphoblastic leukemia (T-ALL).

More Information Supplier Page

CAL-130 50mg 50mg  | Purity Not Available

Adooq Bioscience

CAL-130 is a novel phosphoinositide 3-kinase (PI3K) inhibitor. It is reported that combined inhibition of PI3K??/?? as therapy for T cell acute lymphoblastic leukemia (T-ALL).

More Information Supplier Page

CAL-130 5mg 5mg  | Purity Not Available

Adooq Bioscience

CAL-130 is a novel phosphoinositide 3-kinase (PI3K) inhibitor. It is reported that combined inhibition of PI3K??/?? as therapy for T cell acute lymphoblastic leukemia (T-ALL).

More Information Supplier Page

CAL-130 10mg 10mg  | Purity Not Available

Adooq Bioscience

CAL-130 is a novel phosphoinositide 3-kinase (PI3K) inhibitor. It is reported that combined inhibition of PI3K??/?? as therapy for T cell acute lymphoblastic leukemia (T-ALL).

More Information Supplier Page